Westwood Holdings Group’s Celgene Corp CELG Stock Holding History

Westwood Holdings Group’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,820	Closed	-$236K	–	536
2017 Q2	$236K	Buy	+1,820	New	+$223K	﹤0.01%	385

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Westwood Holdings Group's CELG Position: Q3 2017 in Review

Westwood Holdings Group sold out of Celgene Corp (CELG) in Q3 2017, closing a stake of 1,820 shares — an estimated $236K sold.

Westwood Holdings Group first reported a position in CELG in Q2 2017 and held it in 1 quarter. The position peaked at $236K in Q2 2017. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

Westwood Holdings Group reported no remaining Celgene Corp position as of Q3 2017 after selling out during the quarter.
Westwood Holdings Group sold 1,820 Celgene Corp shares in Q3 2017, an estimated $236K.
Westwood Holdings Group first reported a position in Celgene Corp in Q2 2017 and held it in 1 quarter.
Westwood Holdings Group's Celgene Corp position peaked at $236K in Q2 2017.
1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on Westwood Holdings Group's 13F filing for Q3 2017, filed 14 Nov 2017.